People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

USA: A recent study published in JAMA Network Open has found that the use of glucagon-like peptide-1 (GLP-1) receptor ...

Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

"All of the GLP-1 agonists that we use now cause changes in how everything is secreted in your GI tract," Ann Marie Defnet, ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...